Federal Register / Vol. 87, No. 69 / Monday, April 11, 2022 / Notices 21123 

213, WC Docket No. 20–89 (FCC 20–44), 

establishing two programs designed to 

assist health care providers in providing 

connected care services to consumers— 

the COVID–19 Telehealth Program and 

the Connected Care Pilot Program 

(collectively, Programs). June 2021, the 

Commission adopted a Second Report 

and Order, WC Docket No. 18–213 (FCC 

21–74), that provided guidance on 

eligible services, competitive bidding, 

invoicing, and data reporting for Pilot 

Program participants. The information 

collected herein is necessary to meet the 

specific requirements for information 

that must be submitted as part of the 

annual and final reports to the 

Commission as outlined in the Second 

Connected Care Report and Order, and 

for the Commission to receive and 

evaluate data for the selected projects 

and ensure compliance with the 

Commission’s rules and procedures 

applicable to the Connected Care Pilot 

Program. This submission does not 

make any changes to the previously 

approved information collections for the 

COVID–19 Telehealth Program and 

some of the previously approved 

requirements for the Pilot Program. 

Federal Communications Commission. 

Marlene Dortch, 

Secretary, Office of the Secretary. 

[FR Doc. 2022–07631 Filed 4–8–22; 8:45 am] 

BILLING CODE 6712–01–P 

FEDERAL DEPOSIT INSURANCE 

CORPORATION 

[OMB No. 3064–0207] 

Agency Information Collection 

Activities: Proposed Collection 

Renewal; Comment Request 

AGENCY: Federal Deposit Insurance 

Corporation (FDIC). 

ACTION: Notice and request for comment. 

SUMMARY: The FDIC, as part of its 

obligations under the Paperwork 

Reduction Act of 1995 (PRA), invites the 

general public and other Federal 

agencies to take this opportunity to 

comment on the renewal of the existing 

information collection described below 

(OMB Control No. 3064–0207). 

DATES: Comments must be submitted on 

or before June 10, 2022. 

ADDRESSES: Interested parties are 

invited to submit written comments to 

the FDIC by any of the following 

methods: 

• Agency Website: https://

www.fdic.gov/resources/regulations/ 

federal-register-publications/. 

• Email: comments@fdic.gov. Include 

the name and number of the collection 

in the subject line of the message. 

• Mail: Manny Cabeza (202–898– 

3767), Regulatory Counsel, MB–3128, 

Federal Deposit Insurance Corporation, 

550 17th Street NW, Washington, DC 

20429. 

• Hand Delivery: Comments may be 

hand-delivered to the guard station at 

the rear of the 17th Street NW building 

(located on F Street NW), on business 

days between 7:00 a.m. and 5:00 p.m. 

All comments should refer to the 

relevant OMB control number. A copy 

of the comments may also be submitted 

to the OMB desk officer for the FDIC: 

Office of Information and Regulatory 

Affairs, Office of Management and 

Budget, New Executive Office Building, 

Washington, DC 20503. 

FOR FURTHER INFORMATION CONTACT: 

Manny Cabeza, Regulatory Counsel, 

202–898–3767, mcabeza@fdic.gov, MB– 

3128, Federal Deposit Insurance 

Corporation, 550 17th Street NW, 

Washington, DC 20429. 

SUPPLEMENTARY INFORMATION: 

Proposal to renew the following 

currently approved collection of 

information: 

1. Title: Loans in Areas Having 

Special Flood Hazards. 

OMB Number: 3064–0207. 

Form Number: None. 

Affected Public: Private Sector. 

Burden Estimate: 

BURDEN CALCULATION

[OMB No. 3064–0207] 

Description 

Estimated 

annual 

number of 

respondents 

Estimated 

annual 

number of 

responses per 

respondent 

Estimated 

hours per 

response 

Total hours 

Recordkeeping: 

Private flood Insurance (Required to obtain benefits) .............................. 3,106 1 0.500 1,553.00 

Standard flood hazard determination form (Mandatory) .......................... 3,106 313 0.042 40,831.48 

Retention of notice of special flood hazards and availability of Federal 

disaster relief assistance (Mandatory) .................................................. 3,106 36 0.250 27,954.00 

Disclosure: 

Notice of requirement to escrow flood insurance payments and fees 

(Mandatory) ........................................................................................... 470 82 0.083 3,198.82 

Change in status (Mandatory) .................................................................. 30 2 40 2,400.00 

Notice of option to escrow flood insurance payments and fees (Mandatory) ....................................................................................................... 30 22 0.083 54.78 

Notice to borrower to purchase flood insurance (Mandatory) .................. 3,106 10 0.083 2,577.98 

Notification to terminate flood insurance purchased on behalf of a borrower (Mandatory) ................................................................................. 3,106 1 0.250 776.50 

Notice of special flood hazards and availability of Federal disaster relief 

assistance (Mandatory) ......................................................................... 3,106 36 0.250 27,954.00 

Notice to Administrator of FEMA of servicer’s identity (Mandatory) ........ 3,106 18 0.083 4,640.36 

Notice to Administrator of FEMA of a change in loan servicer (Mandatory) ....................................................................................................... 3,106 22 0.083 5,671.56 

Total Estimated Burden Hours: 

$117,612.48. 

General Description of Collection: 

Each supervised lending institution is 

required to provide a notice of special 

flood hazards to a borrower acquiring a 

loan secured by a building on real 

property located in an area identified by 

FEMA as subject to special flood 

hazards, and various other notices to 

borrowers, servicers and FEMA. The 

Riegle Community Development Act 


lotter on DSK11XQN23PROD with NOTICES1
21124 Federal Register / Vol. 87, No. 69 / Monday, April 11, 2022 / Notices 

requires that each institution also 

provide a copy of the notice to the 

servicer of the loan (if different from the 

originating lender). Section 100239 of 

the Biggert-Waters Flood Insurance 

Reform Act of 2012 requires each 

federal banking agency (including the 

FDIC), and the Farm Credit 

Administration, to adopt implementing 

regulations to direct regulated lending 

institutions to accept ‘‘private flood 

insurance,’’ as defined by the BiggertWaters Act. A lending institution would 

be required to implement policies and 

procedures to comply with the BiggertWaters Act provision and verify in 

writing that a private insurance policy 

satisfies the criteria included in the 

definition or document findings that 

separate required criteria have been met 

when accepting a private flood 

insurance policy in satisfaction of the 

mandatory flood insurance purchase 

requirement of the Flood Disaster 

Protection Act. The institution must 

also maintain records to permit 

examination staff to ascertain how the 

institution has met the requirements of 

the regulation. 

The FDIC has reviewed its previous 

submission related to the PRA and has 

updated its methodology to align with 

the Office of the Comptroller of the 

Currency’s corresponding information 

collection (1557–0326). The decrease in 

the estimated annual burden of 409,935 

hours is the result of this change in 

methodology. 

Request for Comment 

Comments are invited on: (a) Whether 

the collection of information is 

necessary for the proper performance of 

the FDIC’s functions, including whether 

the information has practical utility; (b) 

the accuracy of the estimates of the 

burden of the information collection, 

including the validity of the 

methodology and assumptions used; (c) 

ways to enhance the quality, utility, and 

clarity of the information to be 

collected; and (d) ways to minimize the 

burden of the collection of information 

on respondents, including through the 

use of automated collection techniques 

or other forms of information 

technology. All comments will become 

a matter of public record. 

Federal Deposit Insurance Corporation. 

Dated at Washington, DC, on April 5, 2022. 

James P. Sheesley, 

Assistant Executive Secretary. 

[FR Doc. 2022–07639 Filed 4–8–22; 8:45 am] 

BILLING CODE 6714–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2022–D–0552] 

Safety and Performance Based 

Pathway Device-Specific Guidances; 

Guidance for Industry and Food and 

Drug Administration Staff; Availability 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice of availability. 

SUMMARY: The Food and Drug 

Administration (FDA or Agency) is 

announcing the availability of two final 

device-specific guidance documents for 

the Safety and Performance Based 

Pathway—specifically, ‘‘Surgical 

Sutures—Performance Criteria for Safety 

and Performance Based Pathway’’ and 

‘‘Orthopedic Fracture Fixation Plates— 

Performance Criteria for Safety and 

Performance Based Pathway.’’ The 

device-specific guidances identified in 

this notice were developed in 

accordance with the finalized guidance 

entitled ‘‘Safety and Performance Based 

Pathway.’’ 

DATES: The announcement of the 

guidances is published in the Federal 

Register on April 11, 2022. 

ADDRESSES: You may submit either 

electronic or written comments on 

Agency guidances at any time as 

follows: 

Electronic Submissions 

Submit electronic comments in the 

following way: 

• Federal eRulemaking Portal: 

https://www.regulations.gov. Follow the 

instructions for submitting comments. 

Comments submitted electronically, 

including attachments, to https://

www.regulations.gov will be posted to 

the docket unchanged. Because your 

comment will be made public, you are 

solely responsible for ensuring that your 

comment does not include any 

confidential information that you or a 

third party may not wish to be posted, 

such as medical information, your or 

anyone else’s Social Security number, or 

confidential business information, such 

as a manufacturing process. Please note 

that if you include your name, contact 

information, or other information that 

identifies you in the body of your 

comments, that information will be 

posted on https://www.regulations.gov. 

• If you want to submit a comment 

with confidential information that you 

do not wish to be made available to the 

public, submit the comment as a 

written/paper submission and in the 

manner detailed (see ‘‘Written/Paper 

Submissions’’ and ‘‘Instructions’’). 

Written/Paper Submissions 

Submit written/paper submissions as 

follows: 

• Mail/Hand Delivery/Courier (for 

written/paper submissions): Dockets 

Management Staff (HFA–305), Food and 

Drug Administration, 5630 Fishers 

Lane, Rm. 1061, Rockville, MD 20852. 

• For written/paper comments 

submitted to the Dockets Management 

Staff, FDA will post your comment, as 

well as any attachments, except for 

information submitted, marked and 

identified, as confidential, if submitted 

as detailed in ‘‘Instructions.’’ 

Instructions: All submissions received 

must include the Docket No. FDA– 

2022–D–0552 for ‘‘Surgical Sutures— 

Performance Criteria for Safety and 

Performance Based Pathway’’ or 

‘‘Orthopedic Fracture Fixation Plates— 

Performance Criteria for Safety and 

Performance Based Pathway.’’ Received 

comments will be placed in the docket 

and, except for those submitted as 

‘‘Confidential Submissions,’’ publicly 

viewable at https://www.regulations.gov 

or at the Dockets Management Staff 

between 9 a.m. and 4 p.m., Monday 

through Friday, 240–402–7500. 

• Confidential Submissions—To 

submit a comment with confidential 

information that you do not wish to be 

made publicly available, submit your 

comments only as a written/paper 

submission. You should submit two 

copies total. One copy will include the 

information you claim to be confidential 

with a heading or cover note that states 

‘‘THIS DOCUMENT CONTAINS 

CONFIDENTIAL INFORMATION.’’ The 

Agency will review this copy, including 

the claimed confidential information, in 

its consideration of comments. The 

second copy, which will have the 

claimed confidential information 

redacted/blacked out, will be available 

for public viewing and posted on 

https://www.regulations.gov. Submit 

both copies to the Dockets Management 

Staff. If you do not wish your name and 

contact information to be made publicly 

available, you can provide this 

information on the cover sheet and not 

in the body of your comments and you 

must identify this information as 

‘‘confidential.’’ Any information marked 

as ‘‘confidential’’ will not be disclosed 

except in accordance with 21 CFR 10.20 

and other applicable disclosure law. For 

more information about FDA’s posting 

of comments to public dockets, see 80 

FR 56469, September 18, 2015, or access 

the information at: https://

www.govinfo.gov/content/pkg/FR-2015- 

09-18/pdf/2015-23389.pdf. 


lotter on DSK11XQN23PROD with NOTICES1